<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Seese SE</submitter><funding>NEI NIH HHS</funding><pubmed_abstract>Despite the identification of many genes involved in developmental eye phenotypes, a large percentage of families lack genetic diagnoses, suggesting novel mechanisms remain to be discovered. Large deletions of 16p11.2, 3p14 or 19p13.11 regions involving transcription factors &lt;i>MAZ&lt;/i>, &lt;i>FOXP1&lt;/i> and &lt;i>SIN3B,&lt;/i> correspondingly, along with other genes, have been previously reported in individuals with neurodevelopmental and variable other features, including ocular coloboma and/or microphthalmia; recently, intragenic variants in &lt;i>FOXP1&lt;/i> and &lt;i>SIN3B&lt;/i> have also been shown to cause neurodevelopmental phenotypes, with developmental eye defects reported in a small number of individuals with &lt;i>FOXP1&lt;/i> variants. Through exome sequencing analysis we identified novel splicing variants in &lt;i>MAZ&lt;/i> and &lt;i>SIN3B,&lt;/i> and a recurrent nonsense allele in &lt;i>FOXP1&lt;/i> in unrelated families affected with colobomatous microphthalmia, all with predicted loss-of-function effects; additionally, we report two new families with coloboma and 16p11.2 genomic deletions including &lt;i>MAZ,&lt;/i> one de novo and another inherited from an affected parent. These findings provide further support for a role for &lt;i>FOXP1&lt;/i> in structural eye phenotypes, expanding its spectrum to include colobomatous microphthalmia, and suggest a role for &lt;i>MAZ&lt;/i> and &lt;i>SIN3B&lt;/i> in human eye development and disease.</pubmed_abstract><journal>Journal of medical genetics</journal><pagination>jmg-2025-111125</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12851817</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Intragenic loss-of-function variants in transcription factors &lt;i>MAZ&lt;/i>, &lt;i>FOXP1&lt;/i> and &lt;i>SIN3B&lt;/i> in colobomatous microphthalmia.</pubmed_title><pmcid>PMC12851817</pmcid><funding_grant_id>R01 EY034398</funding_grant_id><funding_grant_id>R01 EY015518</funding_grant_id><pubmed_authors>Reis LM</pubmed_authors><pubmed_authors>Semina EV</pubmed_authors><pubmed_authors>Schneider A</pubmed_authors><pubmed_authors>Bardakjian T</pubmed_authors><pubmed_authors>Seese SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intragenic loss-of-function variants in transcription factors &lt;i>MAZ&lt;/i>, &lt;i>FOXP1&lt;/i> and &lt;i>SIN3B&lt;/i> in colobomatous microphthalmia.</name><description>Despite the identification of many genes involved in developmental eye phenotypes, a large percentage of families lack genetic diagnoses, suggesting novel mechanisms remain to be discovered. Large deletions of 16p11.2, 3p14 or 19p13.11 regions involving transcription factors &lt;i>MAZ&lt;/i>, &lt;i>FOXP1&lt;/i> and &lt;i>SIN3B,&lt;/i> correspondingly, along with other genes, have been previously reported in individuals with neurodevelopmental and variable other features, including ocular coloboma and/or microphthalmia; recently, intragenic variants in &lt;i>FOXP1&lt;/i> and &lt;i>SIN3B&lt;/i> have also been shown to cause neurodevelopmental phenotypes, with developmental eye defects reported in a small number of individuals with &lt;i>FOXP1&lt;/i> variants. Through exome sequencing analysis we identified novel splicing variants in &lt;i>MAZ&lt;/i> and &lt;i>SIN3B,&lt;/i> and a recurrent nonsense allele in &lt;i>FOXP1&lt;/i> in unrelated families affected with colobomatous microphthalmia, all with predicted loss-of-function effects; additionally, we report two new families with coloboma and 16p11.2 genomic deletions including &lt;i>MAZ,&lt;/i> one de novo and another inherited from an affected parent. These findings provide further support for a role for &lt;i>FOXP1&lt;/i> in structural eye phenotypes, expanding its spectrum to include colobomatous microphthalmia, and suggest a role for &lt;i>MAZ&lt;/i> and &lt;i>SIN3B&lt;/i> in human eye development and disease.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-09T07:25:06.507Z</modification><creation>2026-06-09T03:12:11.137Z</creation></dates><accession>S-EPMC12851817</accession><cross_references><pubmed>41339071</pubmed><doi>10.1136/jmg-2025-111125</doi></cross_references></HashMap>